• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情期间睑疖和睑板腺囊肿的发病率:戴口罩的影响

Incidence of hordeola and chalazia during the COVID-19 pandemic: the role of mask wear.

作者信息

Bhakhri Raman, Zoltoski Rebecca, Athar Moheera, Hasan Shaadan

机构信息

Illinois College of Optometry, Chicago, IL, USA.

出版信息

Clin Exp Optom. 2025 Jul;108(5):561-565. doi: 10.1080/08164622.2024.2388125. Epub 2024 Sep 4.

DOI:10.1080/08164622.2024.2388125
PMID:39231540
Abstract

CLINICAL RELEVANCE

Understanding the associations between mask wear and hordeola and chalazia formation are important for eyecare physicians as they may be overlooked as a direct cause. The literature on these possible relationships is limited.

BACKGROUND

The intention of this study was to determine if there was an increased incidence of internal/external hordeola and chalazia secondary to the implementation of mask wear due to the COVID-19 pandemic in an academic clinical setting.

METHODS

A retrospective chart review of electronic medical records at the Illinois Eye Institute was conducted. Cases were categorised into two groups: pre-COVID/pre- mask wear (December 2018-February 2020) and during the pandemic/mask wear (May 2020-July 2022). Demographic data were also compared between the two groups.

RESULTS

A total of 163 cases of hordeola and chalazia were reported pre-COVID, with an increase to 225 during the pandemic/mask wear period. Due to the reduction in patient visits because of COVID restrictions, an incidence analysis was conducted to determine occurrence rates per 1000 visits. The pre-COVID period showed a total incidence rate of 3.06 cases per 1000 patients (hordeola 1.6/chalazia 1.57) while during the mask wearing period the incidence rate increased to 6.32 cases per 1000 patients (hordeola 2.5/chalazions 3.82). A total incidence rate ratio was calculated to be 2.1 (hordeola 1.6/chalazia 2.6) correlating to a greater chance of developing the conditions during mask wear.

CONCLUSIONS

An increase in the incidence of chalazia and hordeola were noted in the mask wear/pandemic group when compared to the pre-mask wear group. Increased mask wear may be a principal cause of hordeola and chalazia.

摘要

临床相关性

了解佩戴口罩与睑腺炎和睑板腺囊肿形成之间的关联,对眼科医生很重要,因为它们可能被忽视作为直接病因。关于这些可能关系的文献有限。

背景

本研究的目的是确定在学术临床环境中,由于新冠疫情实施口罩佩戴后,内/外睑腺炎和睑板腺囊肿的发病率是否增加。

方法

对伊利诺伊眼科研究所的电子病历进行回顾性图表审查。病例分为两组:新冠疫情前/未佩戴口罩时期(2018年12月至2020年2月)和疫情期间/佩戴口罩时期(2020年5月至2022年7月)。还比较了两组的人口统计学数据。

结果

新冠疫情前共报告了163例睑腺炎和睑板腺囊肿病例,在疫情/佩戴口罩期间增加到225例。由于新冠疫情限制导致患者就诊减少,进行了发病率分析以确定每1000次就诊的发生率。新冠疫情前时期每1000例患者的总发病率为3.06例(睑腺炎1.6/睑板腺囊肿1.57),而在佩戴口罩期间发病率增加到每1000例患者6.32例(睑腺炎2.5/睑板腺囊肿3.82)。计算得出总发病率比为2.1(睑腺炎1.6/睑板腺囊肿2.6),这表明在佩戴口罩期间发生这些病症的可能性更大。

结论

与未佩戴口罩组相比,佩戴口罩/疫情组中睑板腺囊肿和睑腺炎的发病率有所增加。增加口罩佩戴可能是睑腺炎和睑板腺囊肿的主要原因。

相似文献

1
Incidence of hordeola and chalazia during the COVID-19 pandemic: the role of mask wear.新冠疫情期间睑疖和睑板腺囊肿的发病率:戴口罩的影响
Clin Exp Optom. 2025 Jul;108(5):561-565. doi: 10.1080/08164622.2024.2388125. Epub 2024 Sep 4.
2
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
3
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
4
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Non-surgical interventions for acute internal hordeolum.急性睑腺炎的非手术干预措施。
Cochrane Database Syst Rev. 2017 Jan 9;1(1):CD007742. doi: 10.1002/14651858.CD007742.pub4.
7
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
8
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.
9
Acupuncture for acute hordeolum.针刺治疗急性睑腺炎
Cochrane Database Syst Rev. 2017 Feb 9;2(2):CD011075. doi: 10.1002/14651858.CD011075.pub2.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.